p38α protein, a key enzyme in the regulation of various cellular functions, plays a crucial role in some diseases, including cancer, chronic inflammation, and neurodegenerative conditions. Since the discovery of p38α, various pharmaceutical companies and numerous research groups have dedicated considerable efforts to develop inhibitors of this protein. However, the results have not met the expectations foreseen to be able to design drugs.
